An in vitro culture system has been developed for the longterm maintenance of primary, human peripheral blood and umbilical cord blood T lymphocytes, which does not rely on the use of stimulatory cytokines, antigen, or mitogens. In these cultures, a monolayer of adherent cells, some spindleshaped and some resembling macrophages, developed within a week. All adherent cells were positive for the extracellular matrix proteins laminin and fibronectin, the intermediate filament vimentin, and for the surface markers major histocompatibility complex class II, platelet-endothelial cell adhesion molecule I (CD31), and E-Selectin (ELAM-1; CD62E). They were negative for the leukocyte common antigen (CD45). the macrophage marker MO-2 (CD14). muscle-specific actin, and Factor VIII-related antigen. These monolayers N VITRO PROPAGATION of primary T lymphocytes has always involved two steps, (1) activation of the T cells with either antigen or mitogen and (2) expansion of the activated T cells with cytokines, usually interleukin-2 (IL-2).'.* T cells that have been cultured in this manner may persist for several months in vitro. These methods are useful for generating T-cell lines specific for a particular antigen or for expanding activated primary T cells.'.' They are not adequate, however, for culturing resting, primary T cells, because they do not express IL-2 receptors. Nor are they useful for studying T-cell biology independent of the effects of IL-2. A tissue culture system that does not require continuous T-cell stimulation would be particularly attractive for studying HIV infection of resting T lymphocytes, as well as the mechanism(s) leading to the initiation and maintenance of viral latency, because it more closely resembles the in vivo situation. In addition, a system in which primary T cells could be maintained in vitro and, at any point, harvested for use may have potential benefit for studying T-cell biology or for clinical applications such as gene therapy.
N VITRO PROPAGATION of primary T lymphocytes has always involved two steps, (1) activation of the T cells with either antigen or mitogen and (2) expansion of the activated T cells with cytokines, usually interleukin-2 (IL-2).'.* T cells that have been cultured in this manner may persist for several months in vitro. These methods are useful for generating T-cell lines specific for a particular antigen or for expanding activated primary T cells.'.' They are not adequate, however, for culturing resting, primary T cells, because they do not express IL-2 receptors. Nor are they useful for studying T-cell biology independent of the effects of IL-2. A tissue culture system that does not require continuous T-cell stimulation would be particularly attractive for studying HIV infection of resting T lymphocytes, as well as the mechanism(s) leading to the initiation and maintenance of viral latency, because it more closely resembles the in vivo situation. In addition, a system in which primary T cells could be maintained in vitro and, at any point, harvested for use may have potential benefit for studying T-cell biology or for clinical applications such as gene therapy.
We have developed a culture system for long-term maintenance of resting, human peripheral blood (PB) and umbilical cord blood (CB) T lymphocytes. T-cell growth was supported by a PB-derived adherent cell monolayer, which was composed of endothelial-like cells. These cells have a phenotype closely resembling that of activated endothelial cells including the expression of E-selectin and HLA-DR. These cells presumably secrete growth factor(s) that can support the maintenance of mature T cells. The T cells appeared to remain in a quiescent phase. They could be harvested from the cultures and stimulated with mitogens or allogeneic cells at any point, thus remaining immunocompetent. Both CD4' and CD8' cells persisted in culture, and the proportion of each cell type remained the same for the duration of the culture. We have harvested T cells from 2-month-old cultures for use as target cells for retroviral vector-mediated gene transfer. Forty-eight hours after cocultivation with helper cells producing a retroviral vector containing the lucZ gene, 20% to 30% of the long-tern-cultured T cells expressed the exogenous gene. This efficiency of infection was similar to that obtained for fresh PB T cells (21% to 28%), suggesting that the long-tern-cultured cells might also be useful, in certain cases, for somatic cell gene therapy protocols.
MATERIALS AND METHODS

Preparation of long-term T-cell cultures.
Mononuclear cells were prepared from human PB or umbilical CB by density separation on Hypaque ficoll (Sigma, St Louis, MO). The entire mononuclear cell fraction was resuspended at a cell density of 0.5 X lo6 cells/ mL either in Dulbecco's modified Eagle's medium supplemented with 20% horse serum (GIBCO, Grand Island, NY) and 50 pmoVL 2-mercaptoethanol (Sigma: Dexter "like" cultures without IL-3)3 or in RPM1 media supplemented with 10% fetal calf serum (GIBCO), 50 pmoVL 2-mercaptoethanol (Whitlock-Wine culture conditions): and 20 ng/mL basic fibroblast growth factor (bFGF PeproTech, Rocky Hill, NJ). Cells were plated in T25 tissue culture flasks (5 mL/flask) and then incubated at 37°C with 5% CO2. The media was changed once a week by pipetting and replacing one-half of the media with fresh media, being careful not to disturb the nonadherent cells. Within the first week, an adherent cell layer began to form, becoming semiconfluent with time, and nonadherent cells resided on top of this layer. Periodically, the nonadherent cells were removed for counting and then returned to the cultures.
We have established long-term cultures from over 10 individuals ranging from newborns to 45-year-old men and women. Eva Engvall, La Jolla Cancer Research Foundation, La Jolla, CA); fibronectin (Telios, San Diego, CA); anti-HLA-DR (Becton Dickinson); and 13 and MO-2 (Coulter). Two different mouse antihuman E-Selectin, 3B7 and 12F9.C2, were used. They were developed at Hoffmann-LaRoche (Nutley, NJ)5 and were a kind gift of Dr Barry Wolitzky. Mouse ascites fluid was used as negative control.
We have tested adherent cells from long-term cultures of 3 different individuals. Each antibody was tested on at least 2 individuals except the mouse antihuman E-Selectin, which were tested on cells of only 1 individual. In each case, 2 to 4 different slides were stained with the same antibody.
T-cell proliferation assay. Fresh PB mononuclear cells and nonadherent cells from long-term cultures harvested after 1 or 3 months 
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A total of 7 x 10' cells per half-area well were plated for 12 hours in medium containing 1.0 ICi 31H1-thymidine. Con A and mitomycin C treatments are described in Materials and Methods. Results are expressed as mean of 3 to 6 cultures; standard deviation was always within 5% to 15% of the mean and has been omitted for simplicity.
Abbreviation: ND, not determined.
were plated in triplicates in half-area 96-well plates (50,000 cells/ well) at 37°C in RPMI media supplemented with 10% fetal calf serum, and 2-mercaptoethano1(50 pmolL), with or without phytohemagglutinin (PHA; 4 pg/mL; Sigma). Forty-eight hours later, cells were pulsed for 8 hours with ['HI-thymidine (1 pCilwe11). Cells were harvested and analyzed for ['HI-thymidine incorporation in a scintillation counter. To assess the baseline proliferation index of unstimulated cells, T cells were harvested from the cultures every 2 weeks, for I O weeks, and were plated for 12 hours at a concentration of 70,000 cells per half-area well with 0.5 pCi of ['HI-thymidine. As a control, the same number of cells were first treated for 1 hour at 37°C with 25 pg/mL of mitomycin C (Sigma) in RPMI and then washed 3 times with PBS. In some experiments, Con A was also added to mitomycin C-treated and untreated cells to control for the effect of mitomycin C. No proliferation were observed in these cultures. Retrovirus vector and virus-producing cells. The MFG-NB retrovirus vector is a Moloney murine leukemia virus (MLV)-based vector containing the lacZ gene fused to an simian virus-40 nuclear localization signal sequence, expressed from the viral long terminal repeat. 6 The vector was packaged using a cell line-producing vector virus comprised mostly of MLV proteins except for the envelope glycoproteins that were derived from gibbon ape leukemia virus (GaLV). This cell line, MMG, was made by transfecting the canine osteosarcoma D17 cell line with each of the following plasmid DNAs, (1) pMFG-NB, (2) pgag-pol,' (3) pGaLVenv: followed by selection with G418 (0.35 mg/mL), GPT (0.25 mg/mL xanthine, 25 pg/mL mycophenolic acid, and 15 pg/mL hypoxanthine), and hygromycin (1.0 pg/mL). Cells were subcloned, and an individual line yielding vector virus stocks of 2.0 X IO7 focus-forming units/ mL was used for all experiments. The titer was quantitated by inocu- lation o f D l 7 cells with serial dilutions o f helper cell supernatant, Inoculated cells were stained with X-gal 2d later. as previously described,'' and foci consisting of 4 to I 6 hlue cells were counted.
The producer cells were periodically tested and always found to be free o f replication-competent virus. Screening for replicationcompetent virus was performed by assaying for reverse transcriptase activity after a 2-week Dl7 amplification step."' The helper rescue assay"' was also performed after D l 7 amplification. using an indicator cell line consisting o f Dl7 cells that were transfected with the dcfective vector BAG." containing the krcZ gene and thc nco gene, and maintained under selection with G418. The BAG-transfected cell line cannot produce vector virus because it lacks the viral frms sequences. If replication-competent virus were present. it would be detected by X-gal staining or G418 selection. 
LONG-TERM BLOOD-DERIVED T-LYMPHOCYTE CULTURES
CB have been reported to contain hematopoietic, pluripotential stem
In an attempt to culture these hematopoietic precursor cells, we applied modified Whitlock-Witted and Dexter' culture conditions, which have been shown to propagate murine pre-B cells and macrophages, respectively, from long-term bone marrow cultures. Because bFGF has been reported to increase the yield of hematopoietic progenitors isolated from human PB by inducing their response to multilineage hematopoietins,'.' 20 to S0 nglmL bFGF was added to some of the cultures. When cultured under Dexterlike conditions with or without bFGF and under the Whitlock-Witte-like conditions with bFGF, both PB and CB mononuclear cells began to form, within 2 weeks, a semiconfluent lawn of adherent, stromal-like cells, on which resided nonadherent cells with lymphocyte morphology. Both cell types remained in culture for up to 3 months. On typing, the lymphocyte population was found to consist exclusively of CD3' T cells.
Further analysis determined that both CD4' and CD8' cells were present in culture. No B cells were detected. Normal ratios of CD4' and CD8' T cells were found at both time points. Figure 2 shows flow cytometric data of a representative long-term PBL culture at initiation and after 1 month in vitro. The results were very similar to the CBL cultures in that the B cells initially present (27% of the cells) could not be detected after 1 month. Cells were also counted at various time points after initiation of culture to assess the total number of surviving cells. The biggest drop in T-cell counts (32%) occurs within the first week of culture. At 4 weeks, an additional 13% are lost, and, at 10 weeks after culture initiation, 16% more cells are lost. We think that most of the cell loss during the first week represents the death of cells damaged during the purification procedure, because the percentage of cell loss decreases to around 15% per month in the subsequent 8 weeks.
In both CBL and PBL cultures after 1 month or 3 months in vitro, the lymphocyte population consisted entirely of CD3' T cells (Figs 1 and 2) . This was independent of whether modified Dexter conditions or Whitlock-Witte conditions with bFGF were applied. It is noteworthy that modified Whitlock-Witte culture conditions without addition of bFGF did not permit the formation of long-term cultures. B cells did not survive under any of the culture conditions used. What is particularly interesting to note was that the percentage of CD4' cells did not decrease even after 3 months in culture, as has been described with long-term IL-2 treatment.' CD8' T cells were also present at both time points; however, a subpopulation of weakly staining CD8' cells initially present in both CBL and PBL cultures did not persist in culture (Figs 1 and 2) . The differences in the percentages of CD8' between the adult and the CB cultures at time 0 and after establishment of long-term cultures (Figs  1 and 2 ) could be caused, in part, by the different proportions of the weakly staining CD8' population.
Because bFGF was needed for the maintenance of the Whitlock-Witte-type cultures even though it has no direct effect on T cells,'" we inferred that the adherent cell layer was dependent on bFGF, and that the stromal-like cells in For personal use only. on October 23, 2017. by guest www.bloodjournal.org From alter the adherent cells' viability. Because Dexter culture conditions require the addition of high amounts of serum (20%) to the media, it was likely that there was enough bFGF (or other growth factors) in the serum to maintain the adherent cells, making the addition of supplementary bFGF unnecessary.
Analysis of DNA synthesis by long-term T cells. Although there was a slow decrease in the number of T cells over a period of 3 months, to assess whether some of these cells do proliferate in culture, we performed two sets of experiments. First, we measured, at 2-week intervals, the incorporation of '[HI-thymidine by unstimulated T cells. As a control for nondividing cells, we used mitomycin C-treated T cells, some of which were also stimulated with Con A (to control for the effect of mitomycin C). As can be seen in Table 1 , thymidine incorporation by untreated T cells was very low, although it was slightly higher than that of mitomycin C-treated cells. This could be because of the fact that mitomycin C treatment results in a faster cell death rate; however, we cannot rule out the possibility that some cells in these long-term cultures are dividing. In a second set of experiments, we measured the amount of newly synthesized DNA by measuring the incorporation of BrdU with fluorescinated anti-BrdU antibodies. Again, we found no evidence of cell division (data not shown).
PB T cells from long-term cultures can be activated with mitogens and respond to allogeneic stimulator cells in mixed lymphocyte reactions. To assess the immune competence of PBL T cells harvested from long-term cultures, we tested their ability to respond to the mitogens PHA and Con A and to allogeneic cells after 6 weeks, 2 months, or 3 months in culture. T-cell proliferation was measured by ['HI-thymidine incorporation. As can be seen in Fig 3, after 6 weeks in culture, the T cells proliferated in response to both mitogens, although the response to PHA was somewhat better. After 3 months in culture, the T-cell response to PHA did not decrease. Allogeneic responses were measured at 2 months against two different stimulator PB cells. As shown in Fig  4, 
the long-term T cells responded to both donor cells as measured by ['H]-thymidine incorporation.
The adherent cell population from the long-term cultures is composed of endothelial-like cells with varied morphology. The phenotype of the supportive adherent cell layer was characterized by immunohistochemistry using a battery of MoAbs specific for the cell surface markers listed in Table 2 . Although all of the adherent cells had an identical antibody-staining profile, morphologically, the cells could be classified into at least two distinct types. Usually, about half the cells had a spindle-shaped morphology, and the other half had a macrophage-like morphology (Fig 5) . The cells were large and stained positively for fibronectin, laminin, and vimentin. Because of their morphology and because the cells were derived from PB or umbilical CB, we suspected their origin to be of the macrophage or endothelial cell lineages, although fibroblasts, dendritic cells, smooth muscle cells, etc were also a possibility. Because the adherent cells did not express either the leukocyte common antigen (CD45) or the macrophage marker MO-2 (CD14), and because macrophages are not known to be dependent on bFGF, we concluded it was unlikely that the cells were macrophages. The cells were also negative for muscle-specific actin, indicating that they are not of smooth muscle origin. The fact that the adherent cells were responsive to bFGF and that they expressed platelet-endothelial cell adhesion molecule-1 (CD31) strongly suggested that they are of endothelial origin.I6.l7 Moreover, all adherent cells, independent of their morphology, stained very strongly with anti-E-selectin (ELAM-I, CD62E) antibodies (Table 2 ). E-selectin is a marker for activated endothelial cells and cannot be detected by staining on resting endothelial cell^.'^ All adherent cells also expressed HLA-DR antigens, a trait that is also characteristic of activated endothelial cells. The cells, however, were negative for Factor VIII-related antigen, another common endothelial cell marker. Therefore, we refer to the cells as endothelial-like.
It is noteworthy that these endothelial-like cells have an antibody-staining profile similar to that of certain Kaposi sarcoma (KS) cell lines,'"'" which also stain positive for some endothelial markers. The origin of KS cells has been a controversial topic; however, it is now generally accepted that they are of endothelial origin.'".'' The KS cell lines also have spindle-like morphology,2",22-'5 and they are also very responsive to bFGF.2',2h~'7 Because it has been reported that these cell lines proliferate in response to PHA-activated Tcell-conditioned media," we added PHA to some of the long-term cultures. Indeed, activation of the T cells by PHA appeared to stimulate growth of the adherent cell layer, most likely by factors secreted by the activated T cells. The adherent cells approximately doubled in number within 5 days of the addition of PHA (data not shown). Interestingly, when the PHA was washed away 24 to 48 hours after addition to the cultures, the stimulated T cells appeared to proliferate for several days and then reverted to a resting morphology. This is in contrast to the characteristic cell death that follows PHA stimulation of purified T cells.
Long-term-cultured T cells can be eficiently infected with a retroviral vector and express the exogenous gene. Because the T cells harvested from the long-term cultures were immune competent, they could be of potential use as target cells for certain gene therapy protocols. To test whether the cells could be efficiently transduced with a retroviral vector containing the lacZ gene with a nuclear localization signal as a marker gene, we infected PBL T cells from 2-monthold cultures, using a protocol originally designed for the infection of fresh primary T cells.'' MMG producer cells (Gu et al, submitted) packaged the MLV-based vector MFG-NB with amphotropic envelope proteins from GaLV ( Fig  6A) . The vector virus produced by these cells can infect human cells. Long-term T cells were stimulated overnight with PHA and were then washed and cocultivated, in the presence of IL-2 and polybrene for 24 hours, with lethallyirradiated MMG cells that produced vector virus at a titer of 2 x lo7 colony-forming units/mL. The target T cells were then harvested and cultured for 48 hours to allow the cells time to express the exogenous lac2 gene. Fresh PB T cells were simultaneously infected as a control. To determine the percentage of cells that expressed the exogenous gene, the target cells were fixed and stained with X-gal, and blue cells For personal use only. on October 23, 2017. by guest www.bloodjournal.org From were counted. As can be seen in Fig 6, on average, 20% to 30% of the 2-month-cultured T cells expressed lacZ after cocultivation (Fig 6B) , as compared with 21% to 28% of the fresh PB T cells (Fig 6C) and uninfected controls ( Fig  6D) . This indicates that the long-term-cultured T cells might be suitable for certain gene therapy applications.
DISCUSSION
The data presented here show that bFGF-responsive adherent cells with surface markers closely resembling those of activated endothelial cells can be cultured from the PB and can support the growth of primary T lymphocytes in vitro for several months. The T-cell population retains the original ratio of CD4+ cells to CD8+ cells and do not proliferate at a high rate, if at all. It is probable that the adherent cells secrete an as yet unknown factor(s) that maintains the T cells in a quiescent state. The resting T cells can be activated to proliferate in response to PHA, even 3 months after the start of the cultures (Fig 3) .
The phenotype of the endothelial-like adherent cells bears resemblance to that described for KS cells. All of the surface markers found on the stromal-like monolayer have been described for various isolates of KS cells, including the fact that some are negative for Factor VIII-related antigen, a common endothelial cell Although the origin of KS cells is somewhat controversial, most seem to concur that they are of endothelial rigi in,'^.^' and they are known to circulate in PB. Studies using bFGF and PHA-stimulated T-cell-conditioned media (CM) indicated that KS cells proliferate in response to bFGF and other cytokines present in like monolayer cells (data not shown). Therefore, it is tempting to speculate that these stromal-like cells might be the normal counterpart of the KS cells.
The development of a system in which primary CD4+ and CD8+ T lymphocytes can be maintained in vitro for long periods of time without the need for activation suggests a number of applications. The most obvious use would be for studies on T lymphocyte biology. Currently, the majority of studies concerning T-cell activation are performed on either T-cell hybridomas or T-cell lines. This is because activated primary T cells must be maintained with IL-2 to survive in vitro, and the effects of IL-2 might obscure the effects of other signaling molecules. For example, the effects of various signaling molecules on the induction of very late antigens could be studied in these long-term T-cell cultures, independent of the effects of exogenous IL-2. Similarly, the effects of molecules that might induce apoptosis of T lymphocytes at various time points postsignaling can also be readily assessed in such a system. It would also be interesting to explore whether thymocytes or other types of cells can be cultured on the stromal-like monolayer. Evidently, B cells are not supported in these cultures (see Figs 1 and 2) .
A second potential application is for studying the interaction of viruses (in particular, HIV) with T lymphocytes. Because, in this system, T cells can be activated with mitogens without induction of massive cell death, the role of various cellular genes such as nuclear factor kappa B, tumor necrosis factor-cy, and other cytokines on the viral life cycle the (".23.26. 27 Similar results were obtained for the stromalcan be readily assessed. Because the infected cells can be maintained for long periods of time, this system is also useful for resolving the controversial issue of latency of HIV infection. In addition, HIV infection of nondividing cells can be directly assessed in such a system. Furthermore, various agents that might be required for or, conversely, block infection could be screened using this in vitro system. A third use of these primary T-cell cultures is in somatic cell gene therapy. Figure 6 shows that the long-term-cultured cells could be efficiently infected with a retroviral vector. Although for most gene therapy applications the use of fresh primary T cells would be preferable to long-termcultured cells, because fresh cells home better after transplantation to the host, it might not always be possible to obtain enough fresh PBLs, especially from newborns. A particular use might be in HIV gene therapy for neonates, once the technology for intracellular immunization protocols has been d e~e l o p e d .~~'~' The umbilical CB from babies born of HIV-positive mothers could be cultured until it is known for certain whether the babies are also infected with HIV. The T cells that arise in these cultures would be amenable to such gene therapy approaches.
